Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2022

Dual Blockade Improves Durability for DME Treatment

David Eichenbaum, MD

Show Description +

David Eichenbaum, MD, explains the 2-year results of treatment with faricimab (Vabysmo, Genentech/Roche) in patients with diabetic macular edema.

Posted: 7/26/2022

Keywords:

Diabetic macular edema, DME

•

DME

•

Clinical Trials

•

retina-meeting-recap

•

faricimab

•

Vabysmo

•

Genentech

•

Roche

Up Next

Home Monitoring for AMD: 10 Years of Data

Home Monitoring for AMD: 10 Years of Data

Michael J. Elman, MD

A Call for Inclusion Efforts in Retina Clinical Trials

A Call for Inclusion Efforts in Retina Clinical Trials

Vivienne S. Hau, MD, PhD

Anti-VEGF Shows Promise for Treating Radiation Retinopathy

Anti-VEGF Shows Promise for Treating Radiation Retinopathy

Amy Schefler, MD

Faricimab in Wet AMD After 2 Years

Faricimab in Wet AMD After 2 Years

Arshad M. Khanani, MD, MA

Retinal Fluid Data Revealed for the PDS

Retinal Fluid Data Revealed for the PDS

Aleksandra V. Rachitskaya, MD, FASRS

High-Dose Aflibercept: Promising Results

High-Dose Aflibercept: Promising Results

Lloyd Clark, MD, FASRS

Back to All Videos

Dual Blockade Improves Durability for DME Treatment

David Eichenbaum, MD

David Eichenbaum, MD, explains the 2-year results of treatment with faricimab (Vabysmo, Genentech/Roche) in patients with diabetic macular edema.

Posted: 7/26/2022

Keywords:

Diabetic macular edema, DME

•

DME

•

Clinical Trials

•

retina-meeting-recap

•

faricimab

•

Vabysmo

•

Genentech

•

Roche

Please log in to leave a comment.

More From ASRS: 2022 Coverage

Home Monitoring for AMD: 10 Years of Data

Home Monitoring for AMD: 10 Years of Data

Michael J. Elman, MD

A Call for Inclusion Efforts in Retina Clinical Trials

A Call for Inclusion Efforts in Retina Clinical Trials

Vivienne S. Hau, MD, PhD

Anti-VEGF Shows Promise for Treating Radiation Retinopathy

Anti-VEGF Shows Promise for Treating Radiation Retinopathy

Amy Schefler, MD

Faricimab in Wet AMD After 2 Years

Faricimab in Wet AMD After 2 Years

Arshad M. Khanani, MD, MA

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2022.